Stellest® vs. MiSight®: Advanced Myopia Management for Children in Metro Detroit

If your child’s prescription increased in the past year, that is not just a glasses update.

It is progression.

Progression means the eye is physically growing longer — a structural change that increases the lifetime risk of retinal detachment, myopic macular degeneration, glaucoma, and early cataracts.

At Michigan Eye Consultants, we treat childhood myopia as a medical condition that requires management — not passive correction.

We offer two evidence-based, clinically validated options:

• Stellest® myopia control lenses (glasses)

• MiSight® 1 day FDA-approved contact lenses

The goal is not to eliminate glasses overnight.

The goal is to slow eye growth and reduce long-term risk

Why Myopia Control Is Different From Regular Glasses

Standard single-vision glasses do one thing:|

They sharpen vision.

They do not address the signal that tells the eye to keep elongating.

Modern myopia management works by altering peripheral retinal defocus — reducing the stimulus for axial elongation.

Less elongation means:

• Slower prescription increases

• Lower final myopia

• Reduced lifetime disease risk

This is preventive eye care

Stellest®: Myopia Control in Glasses Form

Stellest lenses use Highly Aspherical Lenslet Target (HALT) technology.

They look like normal glasses.
They function very differently.

How Stellest Works

• The central zone provides crisp distance correction.

• Surrounding micro-lenslets create a controlled peripheral signal.

• That signal reduces the drive for continued axial elongation.

Clinical data has shown meaningful slowing of myopia progression compared to standard single-vision lenses.

Stellest Is Often Ideal For:

• Younger children (ages 6–10)

• First-time myopes

• Families preferring a non-contact lens solution

• Children are not ready for contact lens responsibility

They are worn full-time like standard glasses — with a medical benefit built in

MiSight® 1 Day: FDA-Approved Myopia Control Contact Lenses

MiSight 1 day is the first FDA-approved soft contact lens for slowing myopia progression in children.

These are not standard contacts.

They are engineered specifically for myopia control.

How MiSight Works

• Central zone corrects distance vision.

• Alternating treatment zones create controlled peripheral defocus.

• The retina receives a signal that slows eye growth.

Multi-year clinical trials demonstrate significant slowing of progression compared to traditional correction.

MiSight May Be Ideal For:

• Active children involved in sports

• Children resistant to wearing glasses

• Older children ready for daily disposable contact lenses

• Families wanting high hygiene compliance (no cleaning solutions required)

Many children as young as 8 can safely wear daily disposable lenses under proper supervision.

Stellest vs. MiSight: How We Help You Decide

Both options are clinically validated.

The decision depends on:

• Age

• Maturity level

• Lifestyle

• Rate of progression

• Baseline prescription

• Family preference

There is no one-size-fits-all approach.

That is why we perform a structured myopia management consultation before recommending treatment

Our Myopia Management Evaluation

This is more comprehensive than a routine eye exam.

We assess:

• Current prescription and progression history

• Binocular vision status

• Corneal health

• Family history of high myopia

• Lifestyle factors (screen time, outdoor exposure)

• Risk profile based on age of onset

We then design a customized management plan.

Progress is monitored over time to determine effectiveness.

If adjustments are needed, we make them.

This is ongoing medical oversight — not a one-time product purchase.

Why Early Intervention Matters

Children diagnosed before age 10 tend to progress faster.

Each year of unchecked progression increases:

• Final prescription

• Retinal stress

• Lifetime disease risk

Even reducing final myopia by 1–2 diopters can significantly reduce long-term complications.

Waiting often means higher eventual risk

Frequently Asked Questions

Is Stellest better than regular glasses?

Yes. Regular glasses correct vision but do not slow progression. Stellest lenses are specifically designed for myopia control.

Is MiSight safe?

Yes. MiSight is FDA-approved for slowing myopia progression in children and has strong safety data when monitored appropriately.

Will this stop my child’s myopia completely?

The goal is to slow progression — not eliminate it. Slower progression means lower long-term risk.

How long does treatment last?

Typically until eye growth stabilizes in the mid-to-late teenage years.

Is this covered by insurance?

Myopia management is typically considered a specialty medical service and may not be fully covered by standard vision plans. Our team discusses fees transparently before starting care.

When Should You Schedule a Consultation?

If:

• Your child’s prescription increased in the last 12 months

• Myopia started before age 10

• One or both parents are myopic

• The prescription is worsening each year

That is progression.

Progression means structural change.

Structural change increases risk.

Early intervention can reduce that risk.

Schedule a Myopia Management Consultation

If your child’s prescription has been increasing, now is the time to evaluate intervention options.

We will assess candidacy, explain the science clearly, and recommend the most appropriate strategy for your child.

Michigan Eye Consultants
29273 Dequindre Rd
Madison Heights, MI 48071

Call 586-302-3222 or book a Myopia Management Consultation Online.